RadNet, Inc. (RDNT)
NASDAQ
Key stats Fiscal year 2025
Income statement
- Revenue
- 2,040,210,000 11.5%
- Net income
- -18,652,000 -767.8%
- Operating income
- 61,992,000
- Earnings per share
- -0.25 -725%
Growth and profitability
- Operating margin
- 3.04
- Net margin
- -0.91
- Return on equity
- -1.71
- Return on assets
- -0.50
Balance sheet
- Total assets
- 3,758,563,000
- Total liabilities
- 2,402,677,000
- Shareholders' equity
- 1,089,890,000
- Cash and equivalents
- 767,215,000
- Debt
- 1,089,919,000
- Net debt
- 322,704,000
- Current ratio
- 1.76
- Debt to equity
- 1.00
Cash flow and ratios
- Operating cash flow
- 298,820,000
Shareholder returns
- Shares outstanding
- 78,774,892
- Book value per share
- 13.84
Company information
- Headquarters
- Los Angeles, CA
- Exchange
- NASDAQ
- Fiscal year end
- 12-31
- Industry (SEC)
- Services-Medical Laboratories
Fiscal year end: · Source: SEC EDGAR
RadNet, Inc. trades on NASDAQ under the ticker symbol RDNT. This page brings together its price chart, company profile, key financial figures and technical indicators.